Hyper-IgD syndrome/mevalonate kinase deficiency: what is new? - Wikidata - wikimedia - TriplyDB

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

http://www.wikidata.org/entity/Q28262203

about

Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra C13orf31 (FAMIN) is a central regulator of immunometabolic function Histopathologic features in a case of hyperimmunoglobulinemia D syndrome.Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology.Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent.Febrile attacks triggered by milk allergy in an infant with mevalonate kinase deficiency.Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.Cell size control - a mechanism for maintaining fitness and function.The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity.

P2860

Q26771260-3ACC3750-E62F-4CDB-B480-4AAEF3E8B14B Q26786973-76FB07CF-9501-4AD5-B890-86CA655501D0 Q28080326-F29D9C79-19E5-475C-8A5B-81F2B6B94F82 Q28115290-804B85C3-9ADA-4586-A0C1-8C4904E8563B Q36537013-405743B2-D7CE-41DF-ACF8-89C141AD060D Q38786210-84560A19-509A-40BA-9982-ED755B3B81B6 Q40105382-72BA381A-AC15-48FE-B937-5652F47E386D Q42395854-AB28F8E1-5DEF-4811-A225-7F8232FF67CB Q45607380-77780D7E-325C-4D99-B645-772C7566CF2F Q47197525-D53E3F6E-9D0E-495B-B8F1-5529BF0E85D3 Q50531937-E38ECFBB-59EE-4975-83B5-AB956693C365 Q52891141-E0E02CA1-437C-4C08-A9F2-57B85D03189F

P2860

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

http://www.wikidata.org/entity/Q28262203

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@ast

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@en

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@nl

type

label

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@ast

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@en

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@nl

prefLabel

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@ast

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@en

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@nl

P1433

Q28262203-C68412C1-43DB-43E6-BFBC-D7D5C4C80E83

P1476

Q28262203-2222AF5C-74F5-4452-9A01-4BDABA12C64E

P2093

Q28262203-6F387DE2-7D12-40C6-BA97-0C09C1F9B07E

P275

Q28262203-47862A0C-970D-44FB-AA59-211859195521

P2860

Q28262203-00CF5AA3-AF23-4070-8D36-D76A7999A572

Q28262203-03EF8783-2DDF-456E-BF05-56DE9FF01DD3

Q28262203-0A57CA18-EFDC-4B95-9BC2-BC57343C6948

Q28262203-1C5B52C0-706C-4682-A337-8D3121E9CC87

Q28262203-2B3BD743-2909-490B-8FD6-909CF3220C78

Q28262203-2C21DF12-CE7D-4532-831D-C7E0D33E7830

Q28262203-3349890A-9B9E-48AF-9ADD-659AE50FF662

Q28262203-339B8214-DFF7-4BF0-B685-C3CFDC2AD5EF

Q28262203-33B5B4F8-E2C4-4A07-A8D5-F3C8F1B13D88

Q28262203-354DA313-DBF7-407A-8C8B-04B850880BED

P2888

Q28262203-EE484970-DE81-4C56-A921-715F47D85431

P304

Q28262203-C3203D1E-3B56-4A27-A66A-67A2ADBCFD42

P31

Q28262203-23C418DD-51D4-465B-8547-F16AB1F6343B

Q28262203-5933595A-9B31-4D0B-AE24-93C678A1713E

P3181

Q28262203-101DB171-2F83-4FFB-9AEF-6A0833B2767C

P356

Q28262203-5AA97638-2A7B-49A5-BC94-EDC03CEA334C

P407

Q28262203-7B8DB7EB-54F3-4DF6-8F4F-D25E8C5F9304

P433

Q28262203-0B45CDA1-46A6-4519-A87D-91A57E3241D0

P478

Q28262203-727F8FFA-75A9-453D-921E-DAFCFAC8D291

P50

Q28262203-451CA353-2690-49C7-8C3D-9D6183347A76

Q28262203-D2662ECB-D88B-4E68-9A35-6DECF8993E78

P5008

Q28262203-962DC7EE-B695-4752-8393-3B205E18815B

P577

Q28262203-AC07995D-239C-4A68-B722-F32228B2D262

Q28262203-B48B0F11-2C4C-4C95-AFE0-1D7BF266CD74

P5875

Q28262203-27B884FD-879C-41E5-ACB1-051CC9066077

P6179

Q28262203-9788BF61-A25F-4A10-85A0-C2591C5057B4

P698

Q28262203-54564914-C432-4DD2-A944-EA765D590B99

P921

Q28262203-827A4FBF-296D-4209-8261-377A1EA90B86

P932

Q28262203-0D23912D-DCAF-4E10-B00D-93F0733E3FC7

P3181

P356

S00281-015-0492-6

P1433

Seminars in Immunopathology

P1476

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

@en

P2093

C M Mulders-Manders

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Weekly oral alendronate in mevalonate kinase deficiency

Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

Neonatal hepatitis as first manifestation of hyperimmunoglobulinemia d syndrome

Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.

The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.

11-Month-Old Infant With Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism.

Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).

Detection of a novel missense mutation in the mevalonate kinase gene in one Chinese family with DSAP

P2888

s00281-015-0492-6

P304

371-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4621376

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00281-015-0492-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Catharina M Mulders-Manders

P5008

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277085597

http://www.w3.org/2001/XMLSchema#string

P6179

1037316162

http://www.w3.org/2001/XMLSchema#string

P698

25990874

http://www.w3.org/2001/XMLSchema#string

P921

mevalonic aciduria

P932

4491100

http://www.w3.org/2001/XMLSchema#string